Announcements Trials

Browse Landscape

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Multiple Myeloma 3 Lymphoma 3 Lung Neoplasms 3 Endometrial Neoplasms 3 Urinary Bladder Neoplasms 2 Ovarian Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Renal Cell 2 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Somatostatinoma 1 Sarcoma 1 Recurrent Lung Squamous Cell Carcinoma 1 Recurrence 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Metastatic Castration-Resistant Prostate Cancer 1 Melanoma 1 Hereditary Sensory and Autonomic Neuropathies 1 Hematologic Neoplasms 1 Glioma 1 Genital Diseases 1 Fallopian Tube Neoplasms 1

Interventions

Paclitaxel 56 Carboplatin 56 Bevacizumab 43 Gemcitabine 20 Taxes 19 pembrolizumab 15 Immunoglobulin G 13 Disulfides 13 Topotecan 12 olaparib 11 Cisplatin 11 niraparib 9 Cyclophosphamide 9 liposomal doxorubicin 8 Specimen Handling 7 Docetaxel 6 Biopsy 6 mirvetuximab soravtansine 5 Nivolumab 5 Magnetic Resonance Spectroscopy 5 Letrozole 5 Hyperthermic Intraperitoneal Chemotherapy 5 Drug Therapy 5 Cytoreduction Surgical Procedures 5 Albumin-Bound Paclitaxel 5 rucaparib 4 pazopanib 4 oregovomab 4 Surgical Procedures, Operative 4 Neoadjuvant Therapy 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Fallopian Tube Neoplasms × sapanisertib × Clear all

NCT03648489 2024-09-20

DICE

Imperial College London

Phase 2 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡